Story perspectives

EPIC Act Faces Backlash Over Drug Price Delays

10/23/2025

33 5

Summary

Story summary

AARP and Patients for Affordable Drug Now (P4AD) oppose the EPIC Act, arguing it would delay access to affordable drug prices.
Rep. Greg Murphy (R) and Rep. Don Davis (D) introduced bill, extending small-molecule drug exclusivity from seven to eleven years before Medicare negotiations.
They say data show increased drug acquisitions and research and development since the Inflation Reduction Act, and warn EPIC could cost $10 billion in taxpayers' money.

1 of 1

Story summary

AARP and Patients for Affordable Drug Now (P4AD) oppose the EPIC Act, arguing it would delay access to affordable drug prices.
Rep. Greg Murphy (R) and Rep. Don Davis (D) introduced bill, extending small-molecule drug exclusivity from seven to eleven years before Medicare negotiations.
They say data show increased drug acquisitions and research and development since the Inflation Reduction Act, and warn EPIC could cost $10 billion in taxpayers' money.